Stock Analiz

Lexeo Therapeutics, Inc. (LXEO) stock forecast and price target

Price $2.87 · data as of November 13, 2026

12-month price target

Average target$20.67
Upside / downside+620.1%
Analysts9
ConsensusStrong buy
Low $9.00Average $20.67High $30.00

Gold marker: average target · white marker: today’s price ($2.87)

Analyst ratings

Strong buy 2Buy 7Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.20+37.8%$0
Next fiscal year
ends December 31, 2027
$-1.37−13.8%$0
Quarter after
ends December 31, 2026
$-0.34−22.8%$0

Consensus of the analysts covering Lexeo Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 3 lowered.

Frequently asked questions

What is the Lexeo Therapeutics stock price target?

The average 12-month target from 9 analysts is $20.67, 620.1% above the current price of $2.87 Targets range from $9.00 to $30.00.

Is Lexeo Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 7 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Lexeo Therapeutics expected to earn?

Analysts expect EPS of $-1.20 for the fiscal year ending December 31, 2026 and $-1.37 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.